NutriBand (NTRB) Non-Current Deferred Tax Liability (2020 - 2021)
NutriBand (NTRB) posted Non-Current Deferred Tax Liability of $525000.0 for Q1 2021, little changed sequentially from $525000.0 in Q1 2020, and little changed YoY from $525000.0 in Q1 2020.
NutriBand (NTRB) Non-Current Deferred Tax Liability (2020 - 2021) Analysis & Trends
NutriBand has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $525000.0 in Q1 2021.
- Quarterly Non-Current Deferred Tax Liability changed 0.0% year-over-year to $525000.0 in Q1 2021, while the trailing twelve-month figure through Jan 2021 was $525000.0 (changed 0.0% YoY) and the FY2021 annual result came in at $525000.0, changed 0.0% from the prior year.
- Non-Current Deferred Tax Liability steadied at $525000.0 in Q1 2021 per NTRB's latest filing, from $525000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $525000.0 in Q1 2020 and troughed at $525000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2021 | 525,000.00 |
| Jan 31, 2021 | 525,000.00 |
| Jan 31, 2020 | 525,000.00 |
| Jan 31, 2020 | 525,000.00 |